rs1130378

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_182925.5(FLT4):​c.3198C>T​(p.Pro1066Pro) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.274 in 1,613,624 control chromosomes in the GnomAD database, including 62,105 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.25 ( 4913 hom., cov: 32)
Exomes 𝑓: 0.28 ( 57192 hom. )

Consequence

FLT4
NM_182925.5 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:7

Conservation

PhyloP100: -0.889

Publications

27 publications found
Variant links:
Genes affected
FLT4 (HGNC:3767): (fms related receptor tyrosine kinase 4) This gene encodes a tyrosine kinase receptor for vascular endothelial growth factors C and D. The protein is thought to be involved in lymphangiogenesis and maintenance of the lymphatic endothelium. Mutations in this gene cause hereditary lymphedema type IA. [provided by RefSeq, Jul 2008]
FLT4 Gene-Disease associations (from GenCC):
  • lymphatic malformation 1
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: ClinGen, Ambry Genetics, Labcorp Genetics (formerly Invitae), G2P
  • capillary infantile hemangioma
    Inheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
  • congenital heart defects, multiple types, 7
    Inheritance: AD Classification: STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae)
  • lymphatic malformation
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • tetralogy of fallot
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.49).
BP6
Variant 5-180616388-G-A is Benign according to our data. Variant chr5-180616388-G-A is described in ClinVar as Benign. ClinVar VariationId is 263044.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.889 with no splicing effect.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.318 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
FLT4NM_182925.5 linkc.3198C>T p.Pro1066Pro synonymous_variant Exon 23 of 30 ENST00000261937.11 NP_891555.2 P35916-2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
FLT4ENST00000261937.11 linkc.3198C>T p.Pro1066Pro synonymous_variant Exon 23 of 30 1 NM_182925.5 ENSP00000261937.6 P35916-2

Frequencies

GnomAD3 genomes
AF:
0.245
AC:
37313
AN:
152096
Hom.:
4917
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.170
Gnomad AMI
AF:
0.251
Gnomad AMR
AF:
0.219
Gnomad ASJ
AF:
0.322
Gnomad EAS
AF:
0.255
Gnomad SAS
AF:
0.334
Gnomad FIN
AF:
0.229
Gnomad MID
AF:
0.323
Gnomad NFE
AF:
0.288
Gnomad OTH
AF:
0.262
GnomAD2 exomes
AF:
0.265
AC:
66588
AN:
251220
AF XY:
0.277
show subpopulations
Gnomad AFR exome
AF:
0.167
Gnomad AMR exome
AF:
0.174
Gnomad ASJ exome
AF:
0.316
Gnomad EAS exome
AF:
0.248
Gnomad FIN exome
AF:
0.227
Gnomad NFE exome
AF:
0.287
Gnomad OTH exome
AF:
0.292
GnomAD4 exome
AF:
0.277
AC:
405478
AN:
1461408
Hom.:
57192
Cov.:
40
AF XY:
0.281
AC XY:
204249
AN XY:
727018
show subpopulations
African (AFR)
AF:
0.170
AC:
5704
AN:
33480
American (AMR)
AF:
0.178
AC:
7978
AN:
44716
Ashkenazi Jewish (ASJ)
AF:
0.313
AC:
8170
AN:
26134
East Asian (EAS)
AF:
0.249
AC:
9886
AN:
39700
South Asian (SAS)
AF:
0.347
AC:
29919
AN:
86246
European-Finnish (FIN)
AF:
0.230
AC:
12230
AN:
53206
Middle Eastern (MID)
AF:
0.354
AC:
2044
AN:
5768
European-Non Finnish (NFE)
AF:
0.281
AC:
312603
AN:
1111776
Other (OTH)
AF:
0.281
AC:
16944
AN:
60382
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.464
Heterozygous variant carriers
0
16987
33975
50962
67950
84937
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
10342
20684
31026
41368
51710
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.245
AC:
37310
AN:
152216
Hom.:
4913
Cov.:
32
AF XY:
0.245
AC XY:
18254
AN XY:
74424
show subpopulations
African (AFR)
AF:
0.170
AC:
7046
AN:
41526
American (AMR)
AF:
0.219
AC:
3344
AN:
15296
Ashkenazi Jewish (ASJ)
AF:
0.322
AC:
1119
AN:
3470
East Asian (EAS)
AF:
0.255
AC:
1323
AN:
5184
South Asian (SAS)
AF:
0.332
AC:
1601
AN:
4824
European-Finnish (FIN)
AF:
0.229
AC:
2427
AN:
10610
Middle Eastern (MID)
AF:
0.327
AC:
96
AN:
294
European-Non Finnish (NFE)
AF:
0.288
AC:
19578
AN:
67986
Other (OTH)
AF:
0.259
AC:
548
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
1479
2957
4436
5914
7393
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
400
800
1200
1600
2000
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.271
Hom.:
5237
Bravo
AF:
0.238
Asia WGS
AF:
0.258
AC:
898
AN:
3478
EpiCase
AF:
0.295
EpiControl
AF:
0.295

ClinVar

Significance: Benign
Submissions summary: Benign:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:4
-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Clinical Genetics, Academic Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Congenital heart defects, multiple types, 7 Benign:1
Aug 10, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
Nov 11, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Hereditary lymphedema type I Benign:1
Aug 10, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.49
CADD
Benign
3.6
DANN
Benign
0.74
PhyloP100
-0.89
Mutation Taster
=98/2
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1130378; hg19: chr5-180043388; COSMIC: COSV56099249; COSMIC: COSV56099249; API